Files
Download Full Text (3.2 MB)
Contents
- Pancreatic Tumor Team Studies Disease Mechanisms, Reverses Conventional Approach
- Patient Helps Underwrite Familial Cancer Study
- Stomach Cancer Protocols Offer Options
- Gastric Cancer's Low Survival Rate and High Relapse Rate Challenge Physicians
- House Call: Environmental Carcinogens: Fact and Fiction
- Protocols: Pancreatic Cancer Protocol Options Include Gemdtabine and Marimastat
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
4-1999
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Abbruzzese, James L.; Evans, Douglas B. (Douglas Brian), 1956-; Pisters, Peter W.T., 1960-; Vauthey, Nicholas; Janjan, N. A. (Nora A.); Lahoti, Sandeep; Raijman, Isaac; Chiao, Paul; Mansfield, Paul; Ajani, Jaffer A.; Evetts, Phyllis; Fairweather, Jackie; Johnson, Flora; Lynch, Patrick; Feig, Barry W., 1959-; Charnsangavej, Chusilp; Pancreatic Neoplasms; Pancreaticoduodenectomy; Antineoplastic Agents; Radiotherapy; Neoadjuvant Therapy; Gemcitabine; Matrix Metalloproteinase Inhibitors; Hydroxamic Acids; marimastat; Endoscopic Ultrasound-Guided Fine Needle Aspiration; NF-kappa B; Trastuzumab; Cetuximab; Stomach Neoplasms; Adenocarcinoma; Laparoscopy; Endosonography; Neoplasm Micrometastasis; Fluorouracil; Cisplatin; Leucovorin; Nausea; Diarrhea; Weight Loss; Environmental Pollutants; Asbestos; Radiation Exposure; Saccharin; Aspartame; Fluoridation; Clinical Trials as Topic; Publications.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Chalaire, Dawn, "OncoLog, Volume 44, Number 04, April 1999" (1999). OncoLog MD Anderson's Report to Physicians (All issues). 76.
https://openworks.mdanderson.org/oncolog/76
Conditions Governing Access
Open